Skip to main content
Clinical Trials/CTRI/2017/02/007929
CTRI/2017/02/007929
Not yet recruiting
Phase 2

Development of Pharmaceutico-Analytical profiles of Marichyadi Lepa and Abhayarishta and their efficacy on Shvitra (Vitiligo) - A Randomized, Single blind trial

IPGT and RA0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
IPGT and RA
Enrollment
60
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
IPGT and RA

Eligibility Criteria

Inclusion Criteria

  • Patients having signs and symptoms of Shvitra (leucoderma)
  • Patient between the age of 16 to 60 years
  • Patients with chronicity of less than 10 years

Exclusion Criteria

  • Patients with Chronicity more than 10 years
  • Patient below the age of 16 and above the age of 60 years
  • Patients having serious cardiac renal hepatic diseases major illness like IDDM NIDDM patches due to burning chemical explosion any other serious systemic illness
  • Gravid and lactating women
  • Cases with Asadhya Lakshanas of Shvitra

Outcomes

Primary Outcomes

Not specified

Similar Trials